Cicero et al., 2025 - Google Patents
Positron emission tomography imaging in multiple sclerosisCicero et al., 2025
- Document ID
- 16556407955191905705
- Author
- Cicero S
- Hansel C
- Rissanen E
- Singhal T
- Publication year
- Publication venue
- Handbook of Imaging in Multiple Sclerosis
External Links
Snippet
Positron emission tomography (PET) is a molecular imaging technique that uses radioisotopes to evaluate biological processes in vivo. While MRI has revolutionized the diagnosis and clinical monitoring of MS, there are several limitations to MRI, particularly in …
- 238000002600 positron emission tomography 0 title abstract description 77
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ricigliano et al. | Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation | |
| Femminella et al. | Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume | |
| Schrepf et al. | A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis | |
| Liu et al. | Prediction of mild cognitive impairment conversion using a combination of independent component analysis and the cox model | |
| Wu et al. | Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography | |
| Politis et al. | Increased PK11195 PET binding in the cortex of patients with MS correlates with disability | |
| Fujishima et al. | Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities | |
| Schroeter et al. | Combined imaging markers dissociate Alzheimer's disease and frontotemporal lobar degeneration–an ALE meta-analysis | |
| Förster et al. | Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease | |
| Kaunzner et al. | Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation | |
| Lorenz et al. | Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease | |
| Taylor et al. | Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies | |
| Appleton et al. | Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer’s disease | |
| Zhao et al. | Subcortical hypermetabolism associated with cortical hypometabolism is a common metabolic pattern in patients with anti-leucine-rich glioma-inactivated 1 antibody encephalitis | |
| Garibotto et al. | Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy | |
| Preziosa et al. | Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis | |
| Schönecker et al. | Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [18F]-PI-2620 tau-PET signal | |
| Qiao et al. | Neuropsychological performance is correlated with tau protein deposition and glucose metabolism in patients with Alzheimer’s disease | |
| Pitombeira et al. | Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study | |
| Chen et al. | Structural and functional differences of the thalamus between drug-naïve Parkinson’s disease motor subtypes | |
| Mosconi et al. | In vivo brain estrogen receptor expression by neuroendocrine aging and relationships with gray matter volume, bio-energetics, and clinical symptomatology | |
| Toma et al. | Cortical volume and thickness across bipolar disorder subtypes in adolescents: a preliminary study | |
| D'Onofrio et al. | Dopaminergic dysfunction in the left putamen of patients with major depressive disorder | |
| Honda et al. | Subjective depressive mood and regional cerebral blood flow in mild Alzheimer's disease | |
| Kang et al. | Distinct cerebral cortical perfusion patterns in idiopathic normal‐pressure hydrocephalus |